
Erasca
(NASDAQ) ERAS
Erasca Financials at a Glance
Market Cap
$5.30B
Revenue (TTM)
$0.00
Net Income (TTM)
$124.55M
EPS (TTM)
$-0.44
P/E Ratio
-38.83
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$16.93
Volume
106,620
Open
$17.17
Price
$16.93
Volume
106,620
Open
$17.17
Previous Close
$16.93
Daily Range
$16.81 - $17.61
52-Week Range
$1.01 - $18.20
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$16.93
Volume
106,620
Open
$17.17
Previous Close
$16.93
Daily Range
$16.81 - $17.61
52-Week Range
$1.01 - $18.20
ERAS News
ERAS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Erasca
Industry
Biotechnology
Sector
Health CareEmployees
103
CEO
Jonathan E. Lim, MD
Website
www.erasca.comHeadquarters
San Diego, CA 92121, US
ERAS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-33%
Return on Capital
-38%
Return on Assets
-31%
Earnings Yield
-2.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.30B
Shares Outstanding
310.80M
Volume
106.62K
Short Interest
0.00%
Avg. Volume
6.01M
Financials (TTM)
Gross Profit
$3.11M
Operating Income
$131.41M
EBITDA
$128.30M
Operating Cash Flow
$95.45M
Capital Expenditure
$128.00K
Free Cash Flow
$95.58M
Cash & ST Invst.
$276.07M
Total Debt
$47.14M
Erasca Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$743.00K
+10.7%
Gross Margin
0.00%
N/A
Market Cap
$5.30B
N/A
Market Cap/Employee
$51.48M
N/A
Employees
103
N/A
Net Income
$29.09M
+9.7%
EBITDA
$31.86M
-1.5%
Quarterly Fundamentals
Net Cash
$228.94M
-7.1%
Accounts Receivable
$2.50M
+8.7%
Inventory
$0.00
N/A
Long Term Debt
$42.07M
-11.0%
Short Term Debt
$5.07M
+9.7%
Return on Assets
-31.44%
N/A
Return on Invested Capital
-38.33%
N/A
Free Cash Flow
$21.72M
+11.6%
Operating Cash Flow
$21.71M
+11.6%



